Sep 19, 2025 7:00 AM - Sep 20, 2025 3:00 PM

DIA India Annual Meeting - 2025

Innovation Through Integration: Shaping the Future of Patient-Centric Healthcare

Overview

The DIA India Annual Meeting is a premier platform that brings together diverse stakeholders from the life sciences, pharmaceutical, and healthcare industries. The conference serves as a hub for innovation, collaboration, and knowledge sharing, addressing key challenges and opportunities across the drug development spectrum. With a focus on advancing healthcare solutions, the meeting fosters discussions that drive impactful outcomes for patients, industry professionals, and regulators alike.

This year’s meeting, DIA India 2025, will feature multiple tracks, covering critical areas such as Clinical Trial Innovation, Pharmacovigilance, Regulatory Science, CMC & Product Quality, Medical Affairs, and Data Science, RWE, and Artificial Intelligence. Each track offers a unique opportunity to explore emerging trends, cutting-edge technologies, and best practices shaping the future of life sciences. Attendees will engage with thought leaders, exchange ideas, and collaborate on solutions to address the evolving needs of the global healthcare ecosystem.

 

Who should attend?

Life science professionals involved in all stages of drug development, from innovation and discovery to post-market applications:
• Pharma, Biotech, and Medical Device Professionals: Leaders in R&D, Clinical Research, Regulatory Affairs, and Drug Safety.
• Regulatory Authorities: Officials from CDSCO, FDA, and other global agencies.
• Academia and Research: Academicians, researchers, and clinical trial experts.
• Service Providers: CROs, technology, and IT solution providers.
• Students & Young Professionals: Aspiring individuals in life sciences, pharmacy & healthcare
• Policy Makers and Industry Associations: Representatives from IPA, IDMA, and public health advocacy groups.

Learning objectives

The DIA India Annual Meeting 2025 aims to foster innovation, collaboration, and knowledge exchange across the life sciences and healthcare sectors. The conference seeks to address critical challenges in drug development, regulatory science, and patient safety while showcasing advancements in technology, data science, and medical affairs.
By bringing together industry leaders, regulators, academicians, and healthcare professionals, the event strives to create actionable insights, promote cross-functional collaboration, and drive impactful outcomes that benefit patients and the global healthcare ecosystem.

Program Committee

  • Fahd  Khan
    Fahd Khan Head Business Development - APAC
    Emmes, India
  • Manjusha  Rajarshi
    Manjusha Rajarshi Founder Regulus Healthcare
    Partner at roots-simplified Research and Consulting LLP, India
  • Sonica Sachdeva Batra, MD
    Sonica Sachdeva Batra, MD Associate Vice President Enterprise Medical Head- Regulatory Solutions
    Indegene, India
  • Sanish  Davis
    Sanish Davis Director R&D
    Janssen Pharmaceutical, India
  • Moin  Don
    Moin Don Founder and CEO, PVCON Consulting, Lead: South Asia Chapter (ISoP),
    International Society of Pharmacovigilance (ISoP), India
  • Gaurav  Mathur, PhD
    Gaurav Mathur, PhD Manager, Regulatory Affairs
    INC GVK Bio, India
  • Viraj  Suvarna
    Viraj Suvarna Independent Healthcare Consultant
    Know Medical Know Business , India

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.